Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
trafermin (4 trials)
fosphenytoin (Cerebyx) (1 trial)
Alveolar Bone Loss (Phase 3)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Eczema (Phase 2)
Periodontal Attachment Loss (Phase 3)
Periodontitis (Phase 3)
Trials (5 total)
Trial APIs (2 total)